Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway

Cudraflavone C (Cud C) is a naturally-occurring flavonol with reported anti-proliferative activities. However, the mechanisms by which Cud C induced cytotoxicity have yet to be fully elucidated. Here, we investigated the effects of Cud C on cell proliferation, caspase activation andapoptosis inducti...

Full description

Bibliographic Details
Main Authors: Castresana, Javier S., Soo, Hsien-Chuen, Chung, Felicia Fei-Lei, Lim, Kuan-Hon, Yap, Veronica Alicia, Bradshaw, Tracey D., Hii, Ling-Wei, Tan, Si-Hoey, See, Sze-Jia, Tan, Yuen-Fen, Leong, Chee-Onn, Mai, Chun-Wai
Format: Article
Published: Public Library of Science 2017
Online Access:https://eprints.nottingham.ac.uk/41232/
_version_ 1848801179612479488
author Castresana, Javier S.
Soo, Hsien-Chuen
Chung, Felicia Fei-Lei
Lim, Kuan-Hon
Yap, Veronica Alicia
Bradshaw, Tracey D.
Hii, Ling-Wei
Tan, Si-Hoey
See, Sze-Jia
Tan, Yuen-Fen
Leong, Chee-Onn
Mai, Chun-Wai
author_facet Castresana, Javier S.
Soo, Hsien-Chuen
Chung, Felicia Fei-Lei
Lim, Kuan-Hon
Yap, Veronica Alicia
Bradshaw, Tracey D.
Hii, Ling-Wei
Tan, Si-Hoey
See, Sze-Jia
Tan, Yuen-Fen
Leong, Chee-Onn
Mai, Chun-Wai
author_sort Castresana, Javier S.
building Nottingham Research Data Repository
collection Online Access
description Cudraflavone C (Cud C) is a naturally-occurring flavonol with reported anti-proliferative activities. However, the mechanisms by which Cud C induced cytotoxicity have yet to be fully elucidated. Here, we investigated the effects of Cud C on cell proliferation, caspase activation andapoptosis induction in colorectal cancer cells (CRC). We show that Cud C inhibits cell proliferation in KM12, Caco-2, HT29, HCC2998, HCT116 and SW48 CRC but not in the non-transformed colorectal epithelial cells, CCD CoN 841. Cud C induces tumorselective apoptosis via mitochondrial depolarization and activation of the intrinsic caspase pathway. Gene expression profiling by microarray analyses revealed that tumor suppressor genes EGR1, HUWE1 and SMG1 were significantly up-regulated while oncogenes such as MYB1, CCNB1 and GPX2 were down-regulated following treatment with Cud C. Further analyses using Connectivity Map revealed that Cud C induced a gene signature highly similar to that of protein synthesis inhibitors and phosphoinositide 3-kinase (PI3K)-AKT inhibitors, suggesting that Cud C might inhibit PI3K-AKT signaling. A luminescent cell free PI3K lipid kinase assay revealed that Cud C significantly inhibited p110β/p85α PI3K activity, followed by p120γ, p110δ/p85α, and p110α/p85α PI3K activities. The inhibition by Cud C on p110β/p85α PI3K activity was comparable to LY-294002, a known PI3K inhibitor. Cud C also inhibited phosphorylation of AKT independent of NFκB activity in CRC cells, while ectopic expression of myristoylated AKT completely abrogated the anti-proliferative effects, and apoptosis induced by Cud C in CRC. These findings demonstrate that Cud C induces tumor-selective cytotoxicity by targeting the PI3K-AKT pathway. These findings provide novel insights into the mechanism of action of Cud C, and indicate that Cud C further development of Cud C derivatives as potential therapeutic agents is warranted.
first_indexed 2025-11-14T19:44:38Z
format Article
id nottingham-41232
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T21:03:21Z
publishDate 2017
publisher Public Library of Science
recordtype eprints
repository_type Digital Repository
spelling nottingham-412322025-09-09T14:03:37Z https://eprints.nottingham.ac.uk/41232/ Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway Castresana, Javier S. Soo, Hsien-Chuen Chung, Felicia Fei-Lei Lim, Kuan-Hon Yap, Veronica Alicia Bradshaw, Tracey D. Hii, Ling-Wei Tan, Si-Hoey See, Sze-Jia Tan, Yuen-Fen Leong, Chee-Onn Mai, Chun-Wai Cudraflavone C (Cud C) is a naturally-occurring flavonol with reported anti-proliferative activities. However, the mechanisms by which Cud C induced cytotoxicity have yet to be fully elucidated. Here, we investigated the effects of Cud C on cell proliferation, caspase activation andapoptosis induction in colorectal cancer cells (CRC). We show that Cud C inhibits cell proliferation in KM12, Caco-2, HT29, HCC2998, HCT116 and SW48 CRC but not in the non-transformed colorectal epithelial cells, CCD CoN 841. Cud C induces tumorselective apoptosis via mitochondrial depolarization and activation of the intrinsic caspase pathway. Gene expression profiling by microarray analyses revealed that tumor suppressor genes EGR1, HUWE1 and SMG1 were significantly up-regulated while oncogenes such as MYB1, CCNB1 and GPX2 were down-regulated following treatment with Cud C. Further analyses using Connectivity Map revealed that Cud C induced a gene signature highly similar to that of protein synthesis inhibitors and phosphoinositide 3-kinase (PI3K)-AKT inhibitors, suggesting that Cud C might inhibit PI3K-AKT signaling. A luminescent cell free PI3K lipid kinase assay revealed that Cud C significantly inhibited p110β/p85α PI3K activity, followed by p120γ, p110δ/p85α, and p110α/p85α PI3K activities. The inhibition by Cud C on p110β/p85α PI3K activity was comparable to LY-294002, a known PI3K inhibitor. Cud C also inhibited phosphorylation of AKT independent of NFκB activity in CRC cells, while ectopic expression of myristoylated AKT completely abrogated the anti-proliferative effects, and apoptosis induced by Cud C in CRC. These findings demonstrate that Cud C induces tumor-selective cytotoxicity by targeting the PI3K-AKT pathway. These findings provide novel insights into the mechanism of action of Cud C, and indicate that Cud C further development of Cud C derivatives as potential therapeutic agents is warranted. Public Library of Science 2017-01-20 Article PeerReviewed Castresana, Javier S., Soo, Hsien-Chuen, Chung, Felicia Fei-Lei, Lim, Kuan-Hon, Yap, Veronica Alicia, Bradshaw, Tracey D., Hii, Ling-Wei, Tan, Si-Hoey, See, Sze-Jia, Tan, Yuen-Fen, Leong, Chee-Onn and Mai, Chun-Wai (2017) Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway. PLoS ONE, 12 (1). e0170551/1-e0170551/20. ISSN 1932-6203 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170551 doi:10.1371/journal.pone.0170551 doi:10.1371/journal.pone.0170551
spellingShingle Castresana, Javier S.
Soo, Hsien-Chuen
Chung, Felicia Fei-Lei
Lim, Kuan-Hon
Yap, Veronica Alicia
Bradshaw, Tracey D.
Hii, Ling-Wei
Tan, Si-Hoey
See, Sze-Jia
Tan, Yuen-Fen
Leong, Chee-Onn
Mai, Chun-Wai
Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title_full Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title_fullStr Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title_full_unstemmed Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title_short Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
title_sort cudraflavone c induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (pi3k)-akt pathway
url https://eprints.nottingham.ac.uk/41232/
https://eprints.nottingham.ac.uk/41232/
https://eprints.nottingham.ac.uk/41232/